Wang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wang Yang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Gang Wu
Department of Cardiology, Shanghai General Hospital-Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China
1 shared publication - Jiaxing Yan
Department of Gastroenterology Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing China
1 shared publication - Jinxin Ma
Department of Gastroenterology, Peking University Traditional Chinese Medicine Clinical Medical School (Xiyuan), Beijing, China
1 shared publication - Lijun Xu
Tibet University of Tibetan Medicine, Lhasa 850000, China
1 shared publication - Qing Xu
Department of Gastroenterology Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing China
1 shared publication - Ting Chen
Department of Gastroenterology Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing China
1 shared publication
Latest Publications
- Top Cited Papers
- 31 March 2023
- Published by Wiley in Phytotherapy Research
- Vol. 37 (5) , 2051-2066
Berberine and health outcomes: An umbrella review
Berberine is a plant extract widely used in clinical practice. This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health‐related outcomes. The PubMed, Cochrane Library, and Embase databases were searched for meta‐analyses of randomized controlled trials (RCTs) assessing the efficacy and safety of berberine from inception to June 30, 2022. The AMSTAR‐2 and GRADE system were used to assess the methodological quality and evidence level of the included meta‐analyses. A total of 11 eligible meta‐analyses were identified from 235 publications, which were published in peer‐reviewed journals between 2013 and 2022. The results revealed that berberine significantly affects blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections as compared to controls. Common side effects of berberine consumption include gastrointestinal symptoms, such as constipation and diarrhea. Berberine is a safe medicinal plant ingredient that improves various clinical outcomes; however, there is a need for improvement of methodological quality in published meta‐analyses. Additionally, the clinical effects of berberine need to be confirmed in high‐quality RCTs.
- 31 March 2023
- Published by Wiley in Phytotherapy Research
- Vol. 37 (5) , 2051-2066
Top Cited PapersBerberine and health outcomes: An umbrella review
Berberine is a plant extract widely used in clinical practice. This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health‐related outcomes. The PubMed, Cochrane Library, and Embase databases were searched for meta‐analyses of randomized controlled trials (RCTs) assessing the efficacy and safety of berberine from inception to June 30, 2022. The AMSTAR‐2 and GRADE system were used to assess the methodological quality and evidence level of the included meta‐analyses. A total of 11 eligible meta‐analyses were identified from 235 publications, which were published in peer‐reviewed journals between 2013 and 2022. The results revealed that berberine significantly affects blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections as compared to controls. Common side effects of berberine consumption include gastrointestinal symptoms, such as constipation and diarrhea. Berberine is a safe medicinal plant ingredient that improves various clinical outcomes; however, there is a need for improvement of methodological quality in published meta‐analyses. Additionally, the clinical effects of berberine need to be confirmed in high‐quality RCTs.
- 1 January 2013
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 74 (1) , 254-258
The effects of craniocerebral and extracranial trauma on the changes in serum testosterone and estradiol in the early stage and their clinical significance
This study aimed to examine the correlation between the alterations in serum sex hormones testosterone (T) and estradiol (E2) in the early stages after craniocerebral and extracranial injuries, to assess the Injury Severity Score (ISS) and Glasgow Coma Scale (GCS) score in patients with multiple injuries, and to investigate the significance of the posttrauma changes in ISS and GCS as well as their ratio. The serum levels of T and E(2) in 95 patients with multiple injuries in the early stages after trauma (within 24 hours) were determined by radioimmune double-antibody method. All the patients were classified by ISS, and among them, those complicated with craniocerebral injury were classified by GCS. The serum sex hormone levels and their ratio in the patients with trauma were compared with those in the control group consisting of 15 healthy persons. In patients with multiple injuries, in the early stage after injury, the serum T level decreased in proportion with the severity of the trauma, whereas the E2 level increased. There was a significant difference in T, E(2), and the ratio of E(2) and T in the severely traumatic group (ISS > 25) as compared with the other groups (p < 0.01). Among the groups complicated with craniocerebral injury that were classified by GCS, there were significant differences in the groups of 5 ≥ GCS ≥ 3 and 8 ≥ GCS > 5, compared with the control group (p < 0.01). The alterations in the serum sex hormones T and E2 levels and their ratio is correlated with the severity of trauma and craniocerebral injury and, thus probably, could serve as an indicator for the evaluation of the trauma severity and possibly in prognosis. Prognostic study, level III.
- 1 January 2013
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 74 (1) , 254-258
The effects of craniocerebral and extracranial trauma on the changes in serum testosterone and estradiol in the early stage and their clinical significance
This study aimed to examine the correlation between the alterations in serum sex hormones testosterone (T) and estradiol (E2) in the early stages after craniocerebral and extracranial injuries, to assess the Injury Severity Score (ISS) and Glasgow Coma Scale (GCS) score in patients with multiple injuries, and to investigate the significance of the posttrauma changes in ISS and GCS as well as their ratio. The serum levels of T and E(2) in 95 patients with multiple injuries in the early stages after trauma (within 24 hours) were determined by radioimmune double-antibody method. All the patients were classified by ISS, and among them, those complicated with craniocerebral injury were classified by GCS. The serum sex hormone levels and their ratio in the patients with trauma were compared with those in the control group consisting of 15 healthy persons. In patients with multiple injuries, in the early stage after injury, the serum T level decreased in proportion with the severity of the trauma, whereas the E2 level increased. There was a significant difference in T, E(2), and the ratio of E(2) and T in the severely traumatic group (ISS > 25) as compared with the other groups (p < 0.01). Among the groups complicated with craniocerebral injury that were classified by GCS, there were significant differences in the groups of 5 ≥ GCS ≥ 3 and 8 ≥ GCS > 5, compared with the control group (p < 0.01). The alterations in the serum sex hormones T and E2 levels and their ratio is correlated with the severity of trauma and craniocerebral injury and, thus probably, could serve as an indicator for the evaluation of the trauma severity and possibly in prognosis. Prognostic study, level III.